Faculty of Medicine, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
UBC Orthopedics, University of British Columbia, Vancouver, British Columbia, Canada.
J Urol. 2015 Jul;194(1):174-9. doi: 10.1016/j.juro.2014.12.096. Epub 2015 Jan 10.
Urinary tract infection is a key issue for long-term intermittent catheterization users. Various catheter designs and methods have evolved to decrease the risk but the evidence remains unclear regarding whether product type improves outcomes. We determined whether single use hydrophilic coated catheters reduced urinary tract infections compared to multiple use polyvinylchloride catheters for children with neurogenic bladder due to spina bifida.
This was a randomized crossover 4-center trial with 2 treatment periods of 24 weeks each, consisting of single use hydrophilic coated catheter and multiple use polyvinylchloride catheter (washed with soap and water, and air dried after each use). Each week participants recorded symptoms and urine results (Multistix® 8SG reagent strip). Primary outcome was person-weeks of urinary tract infection, defined as positive leukocytes plus fever, flank pain, increased incontinence, malaise, or cloudy or odorous urine requiring antibiotic treatment. Individuals were included if they were a child or young adult with spina bifida and used intermittent catheterization as the primary method of bladder emptying.
Calculated sample size was 97. More than 120 patients were screened, of whom 66 were randomized and 45 completed both trial arms. Mean age was 10.6 years. Of the patients 21 were male and 24 were female. Mean ± SD person-weeks of urinary tract infection was 3.42 ± 4.67 in the single use hydrophilic coated catheter group and 2.20 ± 3.23 in the multiple use polyvinylchloride catheter group (p <0.001). There were no statistical differences in weeks of febrile urinary tract infection or antibiotic use.
Results are consistent with the Cochrane Review in that single use hydrophilic coated catheters may not decrease the incidence of symptomatic urinary tract infection in community dwelling chronic intermittent catheterization users when compared to clean multiple use polyvinylchloride catheters.
尿路感染是长期间歇性导尿使用者的一个关键问题。为了降低风险,各种导管设计和方法不断发展,但关于产品类型是否能改善结果的证据仍不清楚。我们确定对于因脊柱裂导致神经源性膀胱的儿童,与多次使用聚氯乙烯导管相比,单次使用亲水性涂层导管是否会降低尿路感染的风险。
这是一项随机交叉 4 中心试验,每个治疗期为 24 周,包括单次使用亲水性涂层导管和多次使用聚氯乙烯导管(每次使用后用肥皂和水清洗并风干)。每周参与者记录症状和尿液结果(Multistix® 8SG 试剂条)。主要结局是个人周的尿路感染,定义为白细胞阳性加上发热、腰痛、失禁增加、不适或混浊或有异味的尿液需要抗生素治疗。如果他们是患有脊柱裂并将间歇性导尿作为主要膀胱排空方法的儿童或年轻成年人,则纳入研究。
计算的样本量为 97 例。筛选了超过 120 名患者,其中 66 名被随机分配,45 名完成了两个试验臂。平均年龄为 10.6 岁。患者中男性 21 例,女性 24 例。单次使用亲水性涂层导管组的尿路感染个人周数平均为 3.42±4.67,多次使用聚氯乙烯导管组为 2.20±3.23(p<0.001)。发热性尿路感染或抗生素使用的周数没有统计学差异。
结果与 Cochrane 综述一致,即与清洁多次使用聚氯乙烯导管相比,单次使用亲水性涂层导管在社区居住的慢性间歇性导尿使用者中可能不会降低症状性尿路感染的发生率。